Precept Management’s Aptose Biosciences, Inc. APTO Stock Holding History

Precept Management’s Portfolio APTO Stock Details APTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-504	Closed	-$309K	–	49
2022 Q1	$309K	Buy	+504	New	+$279K	0.33%	37
2021 Q3	–	Sell	-444	Closed	-$664K	–	116
2021 Q2	$664K	Sell	444 -291	-40%	-$634K	0.28%	59
2021 Q1	$1.98M	Sell	735 -244	-25%	-$484K	1.35%	24
2020 Q4	$1.93M	Sell	979 -346	-26%	-$813K	0.78%	28
2020 Q3	$3.58M	Hold	1,325	–	–	0.88%	33
2020 Q2	$3.76M	Sell	1,325 -400	-23%	-$1.29M	0.72%	41
2020 Q1	$4.61M	Buy	1,725 +725	+73%	+$2.16M	0.57%	30
2019 Q4	$2.55M	Buy	+1,000	New	+$1.3M	1.23%	23

Other funds holding APTO

DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return

SMH

Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SPC

Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return

Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PAWC

P.A.W. Capital Greenwich, Connecticut $36.7M AUM 6.81% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Precept Management's APTO Position: Q2 2022 in Review

Precept Management sold out of Aptose Biosciences, Inc. (APTO) in Q2 2022, closing a stake of 504 shares — an estimated $309K sold.

Precept Management first reported a position in APTO in Q4 2019 and held it in 8 quarters. The position peaked at $4.61M in Q1 2020. 48 funds tracked by Wall St. Rank hold APTO as of Q2 2022.

Precept Management reported no remaining Aptose Biosciences, Inc. position as of Q2 2022 after selling out during the quarter.
Precept Management sold 504 Aptose Biosciences, Inc. shares in Q2 2022, an estimated $309K.
Precept Management first reported a position in Aptose Biosciences, Inc. in Q4 2019 and held it in 8 quarters.
Precept Management's Aptose Biosciences, Inc. position peaked at $4.61M in Q1 2020.
48 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q2 2022.

Based on Precept Management's 13F filing for Q2 2022, filed 15 Aug 2022.